Organon (NYSE: OGN) today announced the US Food and Drug Administration (FDA) approval of the supplemental Biologics License Application (sBLA) for TOFIDENCE ® (tocilizumab-bavi) injection, for ...
The issue seems likely bound for the U.S. Supreme Court, which so far has never ruled a state's execution method to be unconstitutional.
一部の結果でアクセス不可の可能性があるため、非表示になっています。
アクセス不可の結果を表示する